What Needs to Happen for PrEP to Reach All Who Need It? | |
 | We asked providers and community leaders what they thought needed to happen for PrEP to reach everybody who needs it. |
This Week in HIV Research: Non-AIDS Cancers More Common as People With HIV Age | |
A study finds that as people living with HIV continue to age, the prevalence of non-AIDS-defining cancers will go up. |  |
Low Vitamin D Decreases Impact of Statins in People With HIV | |
 | Having low vitamin D levels was associated with diminished impact of statins on cholesterol for participants in the SATURN-HIV study. |
Getting Real on Smoking and HIV Prevention | |
What works and doesn't work for helping people to quit smoking? |  |
An ongoing series to help providers set the foundations of a patient's care.
Starting HIV Treatment Soon After Diagnosis Trims Time to Viral Suppression
Antiretroviral Therapy Not Linked to Condomless Sex in Large U.K. Study
What's the Next Game-Changer in HIV Treatment?
Which HIV Treatment Regimens Are Recommended for Newly Diagnosed Patients?
The field of hepatitis C disease management is in the midst of dramatic change. This series provides overviews, research updates, and more.
Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients
What Are the Hepatitis C Genotypes?
Real-World Hepatitis C Cure Rates Higher With 2 Direct Acting Agents
Hepatitis C Resources, Services and Information
Risk of HCV Reinfection Greatest in High-Risk MSM and Individuals Who Inject Drugs
This Week in HIV Research: Maintenance Therapy Regimen Containing Lamivudine May Be Viable Option
Talking About Fatherhood and Reproductive Health With Heterosexual Men Living With HIV
Condomless Sex, Younger Age Tied to Rising Syphilis Rate in Swiss HIV Group
Current HIV Prevention Methods
HIV Suppression Twice as Likely After Non-AIDS versus AIDS-Related Cancer Diagnosis
One-Quarter in Southern U.S. Study Miss First HIV Care Visit
Why Did the Opioid Epidemic Develop and How Do We Stop It?
Investigational Hepatitis C Drugs Show Promising Results
This Week in HIV Research: Stable Housing Improves Viral Suppression and CD4 Counts
Fat Gains Continue and Lean Mass Falls in Group on Long-Term HIV Therapy
Weight Gain Poses Higher Diabetes Risk With HIV in U.S. Veterans Study
Inflammation in the Brain Continues Even With Undetectable Plasma Viral Load
Cochrane Nonsense Review of HCV Treatment Misses Real Issues of Access to Care
Notice to readers: TheBodyPRO.com's privacy policy was updated on Sept. 20, 2016.
© 2017 Remedy Health Media, LLC. All Rights Reserved
TheBodyPRO.com: About TheBodyPRO.com | Contact TheBodyPRO.com | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
